Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea (Q33944346)

30 July 2017

1 reference

title

Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea (English)

1 reference

30 July 2017

1 reference

1 reference

Zebraski SE

1

1 reference

30 July 2017

Kochenash SM

series ordinal

2

1 reference

30 July 2017

Raffa RB

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

66

1 reference

30 July 2017

23

1 reference

30 July 2017

2221-2231

1 reference

Long-term management of respiratory symptoms in advanced cancer

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Advanced lung disease. Palliation and terminal care.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Dyspnea in terminally ill cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Management of dyspnea and cough in patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Nebulized opioids to treat dyspnea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Nebulized morphine for paroxysmal cough and dyspnea in a nursing home resident with metastatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Nebulized morphine for the relief of dyspnea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Effects of Dihydrocodeine, Alcohol, and Caffeine on Breathlessness and Exercise Tolerance in Patients with Chronic Obstructive Lung Disease and Normal Blood Gases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Heroin inhalation and asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Effect of naloxone on maximal exercise performance and control of ventilation in COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Endogenous opioids modulate the increase in ventilatory output and dyspnea during severe acute bronchoconstriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Effects of naloxone on the sensation of dyspnea during acute respiratory stress in normal adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Clinical application of nebulized opioids for treatment of dyspnoea in patients with malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

The use of nebulized opioids for breathlessness: a chart review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Low-dose nebulized morphine does not improve exercise in interstitial lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Lack of effect of high doses of inhaled morphine on exercise endurance in chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Nebulized morphine in the palliation of dyspnoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Tissue distribution of opioid receptor gene expression in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Opiate action in the pulmonary circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Endorphins and the control of breathing. Ability of naloxone to restore flow-resistive load compensation in chronic obstructive pulmonary disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Absorption and bioavailability of nebulized morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Anatomy of CNS opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Bombesin, calcitonin and leu-enkephalin immunoreactivity in endocrine cells of human lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

An endogenous inhibitor of N-methyltransferase activity and opiate receptor binding in rabbit tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Distribution of opiate-like substances in rat tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

In vivo evidence for the specific binding of human beta-endorphin to the lung and liver of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Binding of [3H][D-Ala2, MePhe4, Gly-ol5] enkephalin, [3H][D-Pen2, D-Pen5]enkephalin, and [3H]U-69,593 to airway and pulmonary tissues of normal and sensitized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Characterization of non-conventional opioid binding sites in rat and human lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Late pulmonary allergic responses in actively but not passively IgE-sensitized rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Quantitative autoradiography of peripheral opioid binding sites in rat lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Met5-enkephalin-arg6-phe7 and its receptor in lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Characterization of methadone receptor subtypes present in human brain and lung tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Specific binding and clearance of [3H]dynorphin (1-13) in the perfused rat lung: an application of the multiple-indicator dilution method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Modulation of cholinergic neurotransmission in guinea-pig airways by opioids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Both the cholinergic and non-cholinergic components of airway excitation are inhibited by morphine in the guinea-pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Modulation of cholinergic neurotransmission in airways by enkephalin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Differential inhibitory effects of opioids on cigarette smoke, capsaicin and electrically-induced goblet cell secretion in guinea-pig trachea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Neuroregulation of mucus secretion by opioid receptors and K(ATP) and BK(Ca) channels in ferret trachea in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Peripheral versus central cardiorespiratory effects of morphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

Dihydrocodeine for breathlessness in "pink puffers".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900434-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(00)00434-3

1 reference

30 July 2017

1 reference